Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from EUDA Health Holdings ( (EUDA) ).
On December 23, 2025, EUDA Health Holdings accelerated its push into longevity and regenerative medicine by launching a comprehensive stem cell therapy platform and opening its first longevity clinic in Shenzhen, China, marking a significant expansion of its presence in the fast-growing Asian longevity sector. Building on earlier moves to secure distribution rights for T-cell immunotherapies from Shenzhen Inno Immune and its plan to acquire Singapore-based GO POSB Organoids, EUDA is upgrading Shenzhen Inno’s cGMP facility into a production and innovation hub that will integrate GO POSB’s induced pluripotent stem cell technology with advanced Japanese stem cell platforms to support immune, skin and healthy-aging treatments. In parallel, the new Shenzhen clinic, established with KB International, will be the first in the region to comprehensively introduce Japanese longevity healthcare technologies, offering advanced stem cell and T-cell therapies, AI-guided life-cycle health management, and a blend of Eastern, Western and functional medicine, positioning EUDA as a front-runner in delivering end-to-end regenerative and longevity-focused care in Asia.
The most recent analyst rating on (EUDA) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on EUDA Health Holdings stock, see the EUDA Stock Forecast page.
More about EUDA Health Holdings
EUDA Health Holdings Limited is a Singapore-based, non-invasive healthcare provider focused on preventive and longevity-focused care across Singapore, Malaysia and China. Listed on NASDAQ, the company aims to serve over 1.8 billion people in a rapidly aging region by offering innovative, science-backed health solutions that shift care from reactive treatment to proactive longevity management, and it also operates a Singapore-based property management business.
Average Trading Volume: 97,922
Technical Sentiment Signal: Sell
Current Market Cap: $105.9M
See more insights into EUDA stock on TipRanks’ Stock Analysis page.